Literature DB >> 20345332

Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.

Neeraj Mishra1, Amit K Goyal, Shailja Tiwari, Rishi Paliwal, Shivani R Paliwal, Bhuvaneshwar Vaidya, Sharad Mangal, Madhu Gupta, Devyani Dube, Abhinav Mehta, Suresh P Vyas.   

Abstract

IMPORTANCE OF THE FIELD: The mucosal delivery of vaccines provides the basis for induction of humoral, cellular and mucosal immune responses against infectious diseases. The delivery of antigens to and through mucosal barriers always remains challenging due to adverse physiological conditions (pH and enzymes) and biological barriers created by tight epithelial junctions restricting transportation of macromolecules. Mucoadhesive and biodegradable polymers offer numerous advantages in therapeutic delivery of proteins/antigens particularly through the mucosal route by protecting antigens from degradation, increasing concentration of antigen in the vicinity of mucosal tissue for better absorption, extending their residence time in the body and/or targeting them to sites of antigen uptake. Furthermore, antigen can be delivered more effectively to the antigen presenting cells by anchoring the ligand having affinity on the surface of carrier for the receptors present on the mucosal epithelial cells. AREAS COVERED IN THIS REVIEW: The present review covers various polymeric carriers, which allow the possibility of modification and manipulation of their properties, thereby, enhancing the effectiveness of mucosal vaccines. This article reviews the recent literature and patents in the field of vaccine delivery using mucoadhesive polymeric carriers. WHAT THE READER WILL GAIN: The reader will gain insights into various natural polymers, synthetic polymers and ligand derived polymeric carrier systems studied to enhance mucosal immunization. TAKE HOME MESSAGE: Biodegradable polymeric carriers represent a promising approach for mucosal delivery of vaccine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345332     DOI: 10.1517/13543771003730425

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  12 in total

1.  Surface characterisation of bioadhesive PLGA/chitosan microparticles produced by supercritical fluid technology.

Authors:  Luca Casettari; Enzo Castagnino; Snjezana Stolnik; Andrew Lewis; Steven M Howdle; Lisbeth Illum
Journal:  Pharm Res       Date:  2011-03-11       Impact factor: 4.200

2.  Flagellin in fusion with human rotavirus structural proteins exerts an adjuvant effect when delivered with replicating but non-disseminating adenovectors through the intrarectal route.

Authors:  Aurélie Girard; Elodie Roques; Bernard Massie; Denis Archambault
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

3.  Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses In The Lung.

Authors:  Yumeng Li; Chuan Wang; Zhenjie Sun; Jian Xiao; Xiaoliang Yan; Yuqing Chen; Jian Yu; Yimou Wu
Journal:  Int J Nanomedicine       Date:  2019-10-08

4.  Engineering Vaccines for Tissue-Resident Memory T Cells.

Authors:  Frances C Knight; John T Wilson
Journal:  Adv Ther (Weinh)       Date:  2021-01-20

5.  Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model.

Authors:  Yi-Wen Liu; Yu-Hung Chen; Jenn-Wei Chen; Pei-Jane Tsai; I-Hsiu Huang
Journal:  Front Microbiol       Date:  2017-07-25       Impact factor: 5.640

6.  Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs.

Authors:  Santosh Dhakal; Xingguo Cheng; John Salcido; Sankar Renu; Kathy Bondra; Yashavantha Shaan Lakshmanappa; Christina Misch; Shristi Ghimire; Ninoshkaly Feliciano-Ruiz; Bradley Hogshead; Steven Krakowka; Kenneth Carson; Joseph McDonough; Chang Won Lee; Gourapura J Renukaradhya
Journal:  Int J Nanomedicine       Date:  2018-10-24

7.  A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis.

Authors:  Carolina R Oliveira; Cíntia M F Rezende; Marina R Silva; Ana Paula Pêgo; Olga Borges; Alfredo M Goes
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

8.  Mucosal vaccine adjuvants update.

Authors:  Joon Haeng Rhee; Shee Eun Lee; Soo Young Kim
Journal:  Clin Exp Vaccine Res       Date:  2012-07-31

Review 9.  Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation.

Authors:  Gourapura J Renukaradhya; Balaji Narasimhan; Surya K Mallapragada
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

10.  Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.

Authors:  Santosh Dhakal; Sankar Renu; Shristi Ghimire; Yashavanth Shaan Lakshmanappa; Bradley T Hogshead; Ninoshkaly Feliciano-Ruiz; Fangjia Lu; Harm HogenEsch; Steven Krakowka; Chang Won Lee; Gourapura J Renukaradhya
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.